Skip to main content

Advertisement

Articles

Page 1 of 17

  1. The limitation of current biomarker of early stage ovarian cancer and the anatomical location of ovarian (depths of the pelvic) make ovarian cancer difficult to be detected in early stage. Growing evidence sho...

    Authors: Lin Cheng, Kun Zhang, Yunan Qing, Dong Li, Manhua Cui, Peng Jin and Tianmin Xu

    Citation: Journal of Ovarian Research 2020 13:9

    Content type: Research

    Published on:

  2. With the improvement of bacterial detection, the theory of the sterile female upper reproductive tract has been frequently challenged in recent years. However, thus far, no researchers have used ovaries as stu...

    Authors: Qi Wang, Lanbo Zhao, Lu Han, Guoxing Fu, Xiaoqian Tuo, Sijia Ma, Qing Li, Yiran Wang, Dongxin Liang, Miaomiao Tang, Chao Sun, Qing Wang, Qing Song and Qiling Li

    Citation: Journal of Ovarian Research 2020 13:8

    Content type: Research

    Published on:

  3. The timing of the first postpartum ovulation is an important factor affecting the timing of estrous resumption in dairy cows. The first postpartum ovulation is delayed in cows producing large amounts of milk w...

    Authors: Eri Furukawa, Tomoyuki Masaki, Kenichiro Sakaguchi, Min Bo, Yojiro Yanagawa, Koichiro Ueda and Masashi Nagano

    Citation: Journal of Ovarian Research 2020 13:7

    Content type: Research

    Published on:

  4. To evaluate the diagnostic performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) for ovarian cancer.

    Authors: Kexin Li, Yuqing Pei, Yue Wu, Yi Guo and Wei Cui

    Citation: Journal of Ovarian Research 2020 13:6

    Content type: Review

    Published on:

  5. The complex regulatory mechanism involved in ovarian follicular development is not completely understood. Neuronal neuropeptide Y (NPY) is involved in the regulation of feeding behavior, energy homeostasis, an...

    Authors: Yoko Urata, Reza Salehi, Patricia D. A. Lima, Yutaka Osuga and Benjamin K. Tsang

    Citation: Journal of Ovarian Research 2020 13:5

    Content type: Research

    Published on:

  6. Lipids are an important source for energy production during oocyte maturation. The accumulation of intracellular lipids binds to proteins to form lipid droplets. This may lead to cellular lipotoxicity. The imp...

    Authors: Shira Raviv, Shay Hantisteanu, Shilhav Meisel Sharon, Yuval Atzmon, Mediea Michaeli and Einat Shalom-Paz

    Citation: Journal of Ovarian Research 2020 13:4

    Content type: Research

    Published on:

  7. The role of lncRNA miR503HG has been investigated in several types of cancer, but its functions in ovarian cancer (OC) is unclear. Analysis of TCGA dataset revealed a 50-fold lower expression level of miR503HG...

    Authors: Ding Zhu, Xueshuang Huang, Fang Liang and Lijing Zhao

    Citation: Journal of Ovarian Research 2020 13:3

    Content type: Research

    Published on:

  8. Acute myeloid leukemia (AML) in monozygotic twins is a rare event and, until now, only a few cases have been reported. Due to improved oncological treatment and cancer survival rates, quality of life considera...

    Authors: Tanja Burnik Papler, Eda Vrtacnik Bokal and Nina Jančar

    Citation: Journal of Ovarian Research 2020 13:2

    Content type: Case report

    Published on:

  9. Secondary cytoreductive surgery (SCS) is possible in selected patients with recurrent epithelial ovarian cancer (EOC). The goal of SCS is complete resection, although chemotherapy is always followed. Delayed i...

    Authors: Soo Young Jeong, Chel Hun Choi, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae and Yoo-Young Lee

    Citation: Journal of Ovarian Research 2019 13:1

    Content type: Research

    Published on:

  11. Ovarian cancer is the most lethal gynaecologic malignancy. Although there are various subtypes of ovarian cancer, high-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer deaths. Chemoresist...

    Authors: Huan Wu, Rongrong Li, Zhiwei Zhang, Huiyang Jiang, Hanlin Ma, Cunzhong Yuan, Chenggong Sun, Yingwei Li and Beihua Kong

    Citation: Journal of Ovarian Research 2019 12:125

    Content type: Research

    Published on:

  12. Alpha-fetoprotein (AFP) plays a crucial role in the management of malignant ovarian germ cell tumors (MOGCTs) and is an important reference index for chemotherapy termination. However, a high level of AFP can ...

    Authors: Xuan Zong, Jia-Xin Yang and Ying Zhang

    Citation: Journal of Ovarian Research 2019 12:124

    Content type: Case report

    Published on:

  13. Endometriosis is considered to be the most intractable cause of female infertility. Administering any type of treatment for endometriosis before in vitro fertilization and embryo transfer (IVF-ET) is an import...

    Authors: Hiroshi Tamura, Hiroaki Yoshida, Hiroyuki Kikuchi, Mai Josaki, Yumiko Mihara, Yuichro Shirafuta, Masahiro Shinagawa, Isao Tamura, Toshiaki Taketani, Akihisa Takasaki and Norihiro Sugino

    Citation: Journal of Ovarian Research 2019 12:123

    Content type: Research

    Published on:

  14. Epithelial ovarian cancer (EOC) is the deadliest female malignancy. The Wnt/β-catenin pathway plays critical roles in regulating embryonic development and physiological processes. This pathway is tightly regul...

    Authors: Vu Hong Loan Nguyen, Rebecca Hough, Stefanie Bernaudo and Chun Peng

    Citation: Journal of Ovarian Research 2019 12:122

    Content type: Review

    Published on:

  15. Increasing researches have demonstrated the critical functions of MicroRNAs (miRNAs) in the progression of malignant tumors, including ovarian cancer. It was reported that miR-552 was an important oncogene in ...

    Authors: Wenman Zhao, Tao Han, Bao Li, Qianyun Ma, Pinghua Yang and Hengyu Li

    Citation: Journal of Ovarian Research 2019 12:121

    Content type: Research

    Published on:

  16. Ovarian cancer has the highest ratio of mortality among gynecologic malignancies. Chemotherapy is one of the most common treatment options for ovarian cancer. However, tumor relapse in patients with advanced t...

    Authors: Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad and Mohammad Reza Abbaszadegan

    Citation: Journal of Ovarian Research 2019 12:120

    Content type: Review

    Published on:

  18. Ovarian cancer (OC) is a type of gynaecological malignancy with high mortality in females. Serous ovarian cancer (SOC) is a distinct subtype of OC with poor early diagnosis. Given the limitations of traditiona...

    Authors: Zhi-Ying Qi, Fang Wang, Ying-Ying Yue, Xue-Wang Guo, Rui-Meng Guo, Hong-Lin Li and Yan-Ying Xu

    Citation: Journal of Ovarian Research 2019 12:118

    Content type: Research

    Published on:

  19. Poly (ADP-ribose) polymerase (PARP) inhibitor, is a milestone in treatment of ovarian cancer. However, there is no real world study from China regarding the clinical outcome of the taking PARP inhibitor (PARPi...

    Authors: Jing Ni, Xianzhong Cheng, Rui Zhou, Xia Xu, Wenwen Guo and Xiaoxiang Chen

    Citation: Journal of Ovarian Research 2019 12:117

    Content type: Research

    Published on:

  20. Cancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individ...

    Authors: Naoko Sasamoto, Ana Babic, Bernard A. Rosner, Renée T. Fortner, Allison F. Vitonis, Hidemi Yamamoto, Raina N. Fichorova, Linda J. Titus, Anne Tjønneland, Louise Hansen, Marina Kvaskoff, Agnès Fournier, Francesca Romana Mancini, Heiner Boeing, Antonia Trichopoulou, Eleni Peppa…

    Citation: Journal of Ovarian Research 2019 12:116

    Content type: Research

    Published on:

  22. Growing evidence indicates that the tumor biomarker cytokeratin 19 fragment (CYFRA21-1) is significant for a variety of cancers. However, its role in epithelial ovarian cancer (EOC) has rarely been reported. I...

    Authors: Chunjing Jin, Minfeng Yang, Xueqiao Han, Haidan Chu, Yan Zhang, Meihong Lu, Zhonghui Wang, Xinxin Xu, Wenwen Liu, Feng Wang and Shaoqing Ju

    Citation: Journal of Ovarian Research 2019 12:114

    Content type: Research

    Published on:

  23. Ovarian cancer is the leading cause of gynecological cancer-related mortality. The novel oncogene S100A10 has been reported to be involved in cancer cell proliferation, invasion and metastasis. The role of S10...

    Authors: Lingzhi Wang, Wei Yan, Xukun Li, Zhihua Liu, Tian Tian, Tanxiu Chen, Liang Zou and Zhumei Cui

    Citation: Journal of Ovarian Research 2019 12:113

    Content type: Research

    Published on:

  24. Ovarian cancer is the leading cause of gynecologic cancer death in the United States despite effective first-line systemic chemotherapy. Cancer stem cells (CSCs) retain the ability to self-renew and proliferat...

    Authors: Elizabeth V. Connor, Caner Saygin, Chad Braley, Andrew C. Wiechert, Sheelarani Karunanithi, Katie Crean-Tate, Fadi W. Abdul-Karim, Chad M. Michener, Peter G. Rose, Justin D. Lathia and Ofer Reizes

    Citation: Journal of Ovarian Research 2019 12:112

    Content type: Research

    Published on:

  25. Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases. At present, the cause of the disease is not fully understood, but many studies have shown that PCOS is associated with genetic and...

    Authors: Faezeh Tadaion Far, Shahideh Jahanian Sadatmahalleh, Saeideh Ziaei and Anoshirvan Kazemnejad

    Citation: Journal of Ovarian Research 2019 12:111

    Content type: Research

    Published on:

  26. Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies. Most OC patients are diagnosed in advanced stages with less than 40% of women cured. However, the possible mechanism underlying tum...

    Authors: Jiayu Shen, Shuqian Yu, Xiwen Sun, Meichen Yin, Jing Fei and Jianwei Zhou

    Citation: Journal of Ovarian Research 2019 12:110

    Content type: Research

    Published on:

  27. Polycystic ovary syndrome (PCOS) is a complex endocrine disorder and regarded as the leading cause of anovulatory infertility. PCOS is characterized by reproductive dysfunction and metabolic disorders. Baicali...

    Authors: Wei Wang, Jiahua Zheng, Na Cui, Lei Jiang, Han Zhou, Dan Zhang and Guimin Hao

    Citation: Journal of Ovarian Research 2019 12:109

    Content type: Research

    Published on:

  28. Ovarian cancer during pregnancy is relatively rare and treatment strategies are inexperienced in surgery and chemotherapy. Multidisciplinary management of advanced epithelial ovarian cancer in pregnant patient...

    Authors: Tianmin Xu, Liang Wang, Yan Jia, Zanhui Jia, Zhuo Li, Shaohai Cui and Manhua Cui

    Citation: Journal of Ovarian Research 2019 12:108

    Content type: Case report

    Published on:

  29. Cisplatin-based chemotherapy is the first-line treatment for ovarian cancer. However, acquired resistance to cisplatin treatment often occurs in epithelial ovarian cancer, and effective and practical methods f...

    Authors: Bo Zhou, Meng Xia, Bin Wang, Niresh Thapa, Lijuan Gan, Chaoyang Sun, Ensong Guo, Jia Huang, Yulan Lu and Hongbin Cai

    Citation: Journal of Ovarian Research 2019 12:107

    Content type: Research

    Published on:

  30. Ovarian carcinoma (OC) is a common cause of death among women with gynecological cancer. MicroRNAs (miRNAs) are believed to have vital roles in tumorigenesis of OC. Although miRNAs are broadly recognized in OC...

    Authors: Yaowei Li and Li Li

    Citation: Journal of Ovarian Research 2019 12:106

    Content type: Research

    Published on:

  31. Epithelial ovarian cancer (EOC) remains the most lethal gynecological cancer in developed countries, indicating the need for further research. Although current cancer models prove useful, they have major limit...

    Authors: Sander Dumont, Ziga Jan, Ruben Heremans, Toon Van Gorp, Ignace Vergote and Dirk Timmerman

    Citation: Journal of Ovarian Research 2019 12:105

    Content type: Review

    Published on:

  32. Young girls before menarche or menstruating adolescent women may experience long-term drug-resistant chronic pelvic pain, as well as other symptoms associated with pelvic mass. In such cases, it is of great im...

    Authors: Krzysztof Gałczyński, Maciej Jóźwik, Dorota Lewkowicz, Anna Semczuk-Sikora and Andrzej Semczuk

    Citation: Journal of Ovarian Research 2019 12:104

    Content type: Review

    Published on:

  33. Epithelial ovarian cancer (EOC) is usually diagnosed late at an advanced stage. Though EOC initially responds to treatment, the recurrence rate is pretty high. The efficacy of different targeted therapies redu...

    Authors: Sudeep Gupta, Shona Nag, Shyam Aggarwal, Amit Rauthan and Narayanankutty Warrier

    Citation: Journal of Ovarian Research 2019 12:103

    Content type: Review

    Published on:

  34. Breast cancer is the most common cancer in young women. Fortunately current survival rates of BC are significant which makes future fertility very important for quality of life of BC survivors. Chemotherapy ca...

    Authors: Cristina Silva, Ana Cristina Ribeiro Rama, Sérgio Reis Soares, Mariana Moura-Ramos and Teresa Almeida-Santos

    Citation: Journal of Ovarian Research 2019 12:102

    Content type: Research

    Published on:

  35. Ovarian carcinoma is a lethal gynecological malignancy. Women with ovarian cancer (OC) are highly recurrent and typically diagnosed at late stage. Ten-eleven translocation protein 3 (TET3) belongs to the famil...

    Authors: Tiefeng Cao, Wenwei Pan, Xiaoli Sun and Huimin Shen

    Citation: Journal of Ovarian Research 2019 12:101

    Content type: Review

    Published on:

  37. Ovarian cancer is the most common gynecological malignancy that causes cancer-related deaths in women today; this being the case, developing an understanding of ovarian cancer has become one of the major drivi...

    Authors: Yingyu Dou, Xiaoyan Jiang, Hui Xie, Junyu He and Songshu Xiao

    Citation: Journal of Ovarian Research 2019 12:99

    Content type: Review

    Published on:

  38. Endometriosis patients undergoing in vitro fertilization-embryo transfer (IVF-ET) treatment suffer from lower success rates. The success of IVF-ET is related to the receptivity of the uterus and the quality of...

    Authors: Yu Liang, Xiaokui Yang, Yonglian Lan, Lingling Lei, Ying Li and Shuyu Wang

    Citation: Journal of Ovarian Research 2019 12:98

    Content type: Research

    Published on:

  39. Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder characterized by obesity, hyperandrogenism, and insulin resistance. Intercellular adhesion molecule-1 (ICAM-1) is a proinflammatory ...

    Authors: Nearmeen M. Rashad, Amal S. El-Shal, Hala G. Abomandour, Amr Mostafa Kamel Aboelfath, Mohamed el sayed Rafeek, Mohammad Samir Badr, Ayman E. Ali, Mohammed S. Yousef, Maha Abdelhamid Fathy and Mustafa taha Abdelfattah Sharaf el din

    Citation: Journal of Ovarian Research 2019 12:97

    Content type: Research

    Published on:

  40. Development of a hyper-gonadotropic hypoestrogenism condition in women < 40 years, defined as premature ovarian insufficiency (POI), is the most common long-term complication in female survivors of galactosemi...

    Authors: Marzieh Rostami Dovom, Mahsa Noroozzadeh, Nariman Mosaffa, Azita Zadeh–Vakili, Abbas Piryaei and Fahimeh Ramezani Tehrani

    Citation: Journal of Ovarian Research 2019 12:96

    Content type: Review

    Published on:

  41. Large cell neuroendocrine carcinoma is a very rare ovarian neoplasm that has a poor clinical outcome even in the early stage, and there is as yet no established treatment. Diagnostic laparoscopy has been used ...

    Authors: Hideaki Tsuyoshi, Kenji Yashiro, Shizuka Yamada, Makoto Yamamoto, Toshimichi Onuma, Tetsuji Kurokawa and Yoshio Yoshida

    Citation: Journal of Ovarian Research 2019 12:95

    Content type: Case report

    Published on:

  42. The polycystic ovary syndrome (PCOS) is a reproductive endocrine disorder, clinically characterized by oligo-ovulation/chronic anovulation, menstrual irregularities, hyperandrogenism (such as hirsutism, acne),...

    Authors: Zeng-Hong Wu, Yun Tang, Xun Niu, Fei-Fei Pu, Xi-Yue Xiao and Wen Kong

    Citation: Journal of Ovarian Research 2019 12:94

    Content type: Review

    Published on:

  43. The ST6Gal-I glycosyltransferase, which adds α2–6-linked sialic acids to N-glycosylated proteins is upregulated in a wide range of malignancies including ovarian cancer. Prior studies have shown that ST6Gal-I-med...

    Authors: Kaitlyn A. Dorsett, Robert B. Jones, Katherine E. Ankenbauer, Anita B. Hjelmeland and Susan L. Bellis

    Citation: Journal of Ovarian Research 2019 12:93

    Content type: Research

    Published on:

  44. AB209371 gene has been characterized as an oncogenic lncRNA in liver cancer. However, its involvement in ovarian carcinoma (OC) is unknown. In the present study, we analyzed the roles of AB209371 in OC. We fou...

    Authors: Zi-Hui Zheng, Dong-Mei Wu, Shao-Hua Fan, Xin Wen, Xin-Rui Han, Shan Wang, Yong-Jian Wang, Zi-Feng Zhang, Qun Shan, Meng-Qiu Li, Bin Hu, Yuan-Lin Zheng and Jun Lu

    Citation: Journal of Ovarian Research 2019 12:92

    Content type: Research

    Published on:

  45. A retrospective case-control study was performed to evaluate whether PCOS-specific serum markers would change in women with polycystic ovary syndrome (PCOS) during the course of two consecutive cycles of clomi...

    Authors: Marlene Hager, Steffen Hörath, Peter Frigo, Marianne Koch, Rodrig Marculescu and Johannes Ott

    Citation: Journal of Ovarian Research 2019 12:91

    Content type: Research

    Published on:

  46. Phospholipase C (PLC) can participate in cell proliferation, differentiation and aging. However, whether it has a function in apoptosis in porcine primary granulosa cells is largely uncertain. The objective of...

    Authors: Huali Chen, Youfu Yang, Youlin Wang, Yuan Li, Yamei He, Jiaxin Duan, Dejun Xu, Yifei Pei, Jianyong Cheng, Li Yang, Rongmao Hua, Xiaoya Li, Jie Wang, Xiaohan Jiang, Huanshan He, Lin Wu…

    Citation: Journal of Ovarian Research 2019 12:90

    Content type: Research

    Published on:

  47. Gonadoblastoma (GB) is a rare mixed germ cell-sex cord-stromal tumour, first described in humans, commonly found in dysgenetic gonads of intersex patients that have a Y chromosome. However, this entity in not ...

    Authors: Ana R. Flores, João Lobo, Francisco Nunes, Alexandra Rêma, Paula Lopes, Luís Carvalho, Carla Bartosch, Irina Amorim and Fátima Gärtner

    Citation: Journal of Ovarian Research 2019 12:89

    Content type: Case report

    Published on:

  48. Epithelial ovarian cancer (EOC) is the majority ovarian cancer (OC) type with a poor prognosis. This present study aimed to investigate potential prognostic factors including albumin-to-fibrinogen ratio (AFR) ...

    Authors: Wen Yu, Zhongxue Ye, Xi Fang, Xingzhi Jiang and Yafen Jiang

    Citation: Journal of Ovarian Research 2019 12:88

    Content type: Research

    Published on:

  49. This study aimed to examine the performance of the four risk of malignancy index (RMI) in discriminating borderline ovarian tumors (BOTs) and benign ovarian masses in daily clinical practice.

    Authors: Shuang Zhang, Shan Yu, Wenying Hou, Xiaoying Li, Chunping Ning, Yingnan Wu, Feng Zhang, Yu Fei Jiao, Leo Tsz On Lee and Litao Sun

    Citation: Journal of Ovarian Research 2019 12:87

    Content type: Research

    Published on:

Submit manuscript

Annual Journal Metrics

Advertisement

Journal of Ovarian Research

ISSN: 1757-2215

Contact us